He is an Assistant Professor, North Ontario School of Medicine, Lakehead University, and Chief of Dentistry, Thunder Bay Regional Health Sciences Center
They changed the name, by the way, from nonalcoholic fatty liver disease to metabolic-associated fatty liver disease, which just kind of tell you-- and so those people, if they come in with liver failure, they get crazy, literally
Deviating from subcutaneous injection may result in stronger initial peaks followed by premature decline in drug levels, leading to inconsistent appetite suppression and suboptimal weight loss outcomes
ARD-101 is an oral medication that targets bitter taste receptors to suppress appetite, making it a unique addition to the list of weight loss drugs